World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...
Health on MSN

How peptides for weight loss work

Medically reviewed by Anju Goel, MD Peptide medications require a prescription and are intended for long-term use with a balanced diet and exercise.Wegovy and Saxenda can help reduce appetite and ...
Forbes

Weight Loss Drug Saxenda May Make WHO List: Could Help Make It Cheaper Worldwide

World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...
Seeking Alpha

Study finds 30% of Wegovy, Saxenda users quit within 4 weeks

Approximately 30% of people who took the GLP-1 weight-loss drugs Saxenda and Wegovy between 2014 and 2023 discontinued them within four weeks of use, according to a new study by Blue Cross Blue Shield ...